Skip to main content
Premium Trial:

Request an Annual Quote

Sigma-Aldrich, Elchrom Scientific


Sigma-Aldrich announced this week the launch of its Panorama Human p53 Protein Functional Microarray. Developed by Procognia and distributed exclusively by Sigma-Aldrich, the p53 protein microarray contains wild type human p53 and 49 of its variants. Each variant contains a mutation or single nucleotide polymorphism that results in an amino acid change or a truncation. The array is based on a novel and proprietary technology that ensures the protein is correctly folded and confers full functionality, the company said.

Elchrom Scientific introduced this week its Blot-EX — a new non-acrylmaide, not-toxic, high resolution electrophoresis precast hydrogel that was designed to increase protein transfer efficiency during Western blotting.

According to the Cham, Switzerland-based company, Blot-EX offers overall recovery efficiency of up to 90 percent, which can be obtained in less than 10 minutes — a significantly reduced transfer time when compared to industry standard polyacrylamide pre-cast gels.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.